TGFB1 and neoplasm: TGFβ1, 10 ng/ml, treatment increased not only the number but also the diameter of the BxPC-3 tumor spheres, and this effect could be reversed by the TGFβ1 receptor inhibitor SB431542 (10 μM) (Figures 6E–6G).